Enhanced IL-6 trans-signaling in pulmonary arterial hypertension and its potential role in disease-related systemic damage
Authors:
- Malgorzata JasiewiczMJMalgorzata Jasiewicz
- Malgorzata KnappMalgorzata Knapp
- Ewa WaszkiewiczEWEwa Waszkiewicz
- Katarzyna Ptaszynska-KopczynskaKPKatarzyna Ptaszynska-Kopczynska
- Anna SzpakowiczASAnna Szpakowicz
- Bozena SobkowiczBSBozena Sobkowicz
- Wlodzimierz Jerzy MusialWMWlodzimierz Jerzy Musial
- Karol Adam KaminskiKarol Adam Kaminski
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Interleukin-6 and its receptors: A highly regulated and dynamic systemCytokine, 2014
- Serum levels of CD163 and TWEAK in patients with pulmonary arterial hypertensionCytokine, 2014
- IL-6 Trans-Signaling via the Soluble IL-6 Receptor: Importance for the Pro-Inflammatory Activities of IL-6International Journal of Biological Sciences, 2012
- Osteopontin in Patients With Idiopathic Pulmonary HypertensionChest, 2011
- Coronary sinus concentrations of interleukin 6 and its soluble receptors are affected by reperfusion and may portend complications in patients with myocardial infarctionAtherosclerosis, 2009
- Pathology of Pulmonary HypertensionClinics in Chest Medicine, 2007
- Dendritic cell recruitment in lesions of human and experimental pulmonary hypertensionEuropean Respiratory Journal, 2006
- Increased plasma monocyte chemoattractant protein‐1 level in idiopathic pulmonary arterial hypertensionRespirology, 2006
- Molecular and cellular basis of pulmonary vascular remodeling in pulmonary hypertensionProgress in Cardiovascular Diseases, 2002
- Increased Interleukin-1 and Interleukin-6 Serum Concentrations in Severe Primary Pulmonary HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 1995